ETFs: Drug Pricing Policy Shapes PPH Risks in 2026
The VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
Understanding when index funds are worth it depends on time horizon and fees. This quick guide outlines key scenarios and considerations.
14,180 articlesThe VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
U.S. stocks edged higher for the week even as oil prices surged, propelled by resilient corporate results and bets th...
Tech-driven gains keep the Nasdaq Composite in play as AI optimism fuels trading. This update tracks live nasdaq comp...
Markets react to a surprising Air Force One seat allocation featuring Nvidia’s CEO, sparking chatter that export lice...
The internet computer (icp) tumbles about 10% in a broad crypto selloff, weakening after Coinbase removed several ICP...
President Trump’s China visit yielded no major pact, leaving investors and households awaiting clearer benefits. Anal...
Looking for nasdaq stocks before they soar in 2026? This article uncovers two compelling growth names, the catalysts ...
Nvidia's upcoming earnings could be the turning point for AI stocks. This article breaks down what to watch, possible...
NVIDIA posted a blowout quarter as AI demand drives data-center growth, fueling bets that the company will form trill...
Investors are pricing rate hikes through 2027 as the Fed cuts outlook fades, reshaping bond yields and stock valuatio...
A heated AI race has intensified as Google doubles down on AI integration amid OpenAI momentum. Critics raise a provo...
As hyperscalers pour money into AI and data centers, a select pair of stocks stands out for long-term holders. Vertiv...